All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @abbeyskitchen on TikTok · 120s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @abbeyskitchen's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00What I eat in a day on semi-glutide down 46 pounds.
  2. 0:04Okay, this girl's o-sen pick what in a days in the car
  3. 0:08are just going super viral right now.
  4. 0:10So I'm a day-tician, let's unpack.
  5. 0:12For breakfast, I had my cinnamon roll baked oats
  6. 0:15and an iced protein coffee.
  7. 0:18Holy moly, girl, do not get keep the recipe
  8. 0:22for those cinnamon roll baked oats.
  9. 0:23They look insanely good.
  10. 0:25And if you have not already tried protein shakes
  11. 0:27as like the milk in your latte, get on that guys.
  12. 0:30It is life changing, especially while it's still hot out.
  13. 0:34Looks amazing.
  14. 0:34Then for lunch, I had four of these mini chicken pot pies
  15. 0:39that I made for meal prep this week.
  16. 0:41Of course, I had a diet cook for the haters.
  17. 0:45I just realized it's been way too long
  18. 0:47since I've had chicken pot pies.
  19. 0:48And mini anything, they just hit different.
  20. 0:51I'd probably serve this with like some veggies
  21. 0:53on the side for some fiber, but because those
  22. 0:56epic suppresses uptake so aggressively,
  23. 0:58you actually don't want to overly fill up
  24. 1:00on high volume foods before your protein.
  25. 1:03So what she's doing here by prioritizing the protein
  26. 1:06definitely makes sense.
  27. 1:08And for dinner, I made sweet potato sloppy joe bowls.
  28. 1:12It's lean ground beef and a low-cal sweet tomato sauce,
  29. 1:17spicy pickles, red onion, and oven roasted sweet potatoes.
  30. 1:22This looks so good.
  31. 1:23I love spicy pickles, anything.
  32. 1:25I think if I serve my meal, I would like chuck
  33. 1:26some frozen veggies while simmering like with the meat,
  34. 1:29but this day of eating looks incredible.
  35. 1:32If you're on any kind of a GLP one agonist protein
  36. 1:35needs to be the number one priority.
  37. 1:37And that's basically to prevent
  38. 1:39or at least reduce the risk of muscle loss.
  39. 1:42So if you're thinking like 113 grams of protein is a lot,
  40. 1:45it's actually around 30% of her calories,
  41. 1:47which is exactly what best practices
  42. 1:50for fat loss would recommend.
  43. 1:52I would worry a lot more about her cardi-telling,
  44. 1:54like eating all those messy sauces in the front seat,
  45. 1:57but these meals look great to me.
  46. 1:59Next.

Abbey Sharp's protein advice for Ozempic users, fact-checked

Abbey Sharp

TikTok creator

3.8M viewsWatch on TikTok

Quick answer

Semaglutide and other GLP-1 receptor agonists produce significant caloric restriction through appetite suppression and delayed gastric emptying, which creates a real risk of lean muscle mass loss if dietary protein is inadequate. Current evidence supports targeting approximately 1.2 to 1.6 grams of protein per kilogram of body weight daily during GLP-1-assisted weight loss, ideally combined with resistance training. A 30% protein calorie target, as cited in the video, can approximate this range depending on total caloric intake, but individual needs vary and should be assessed by a qualified provider.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 7 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Abbey Sharp's protein advice for Ozempic users, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Abbey Sharp's protein advice for Ozempic users, fact-checked" from Abbey Sharp. We read the clip as a GLP-1 social video fact-checks claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Semaglutide and other GLP-1 receptor agonists produce significant caloric restriction through appetite suppression and delayed gastric emptying, which creates a real risk of lean muscle mass loss if dietary protein is inadequate.

The reason this review is not generic is the source wording and the canonical claim label "glp1 when you re on a glp1 receptor agonist like ozempic every b." In this clip, the useful excerpt is: "What I eat in a day on semi-glutide down 46 pounds." That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Current research supports 1.
People who land here are usually comparing the Compounded Semaglutide claim with [object Object].
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Semaglutide and other GLP-1 receptor agonists produce significant caloric restriction through appetite suppression and delayed gastric emptying, which creates a real risk of lean muscle mass loss if dietary protein is inadequate.

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • Semaglutide and other GLP-1 receptor agonists produce significant caloric restriction through appetite suppression and delayed gastric emptying, which creates a real risk of lean muscle mass loss if dietary protein is inadequate. Current evidence supports targeting approximately 1.2 to 1.6 grams of protein per kilogram of body weight daily during GLP-1-assisted weight loss, ideally combined with resistance training. A 30% protein calorie target, as cited in the video, can approximate this range depending on total caloric intake, but individual needs vary and should be assessed by a qualified provider.
  • A 2023 study (Wilding et al., Diabetes, Obesity and Metabolism) found up to 40% of weight lost on semaglutide was lean mass without structured protein and exercise interventions.
  • Current research supports 1.2 to 1.6 grams of protein per kilogram of body weight daily during caloric restriction, per a 2020 meta-analysis by Stokes et al. in Advances in Nutrition.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • A 2023 study (Wilding et al., Diabetes, Obesity and Metabolism) found up to 40% of weight lost on semaglutide was lean mass without structured protein and exercise interventions.
  • Current research supports 1.2 to 1.6 grams of protein per kilogram of body weight daily during caloric restriction, per a 2020 meta-analysis by Stokes et al. in Advances in Nutrition.
  • Protein percentage targets like 30% of calories can be a useful approximation, but body-weight-based protein calculations are more precise and clinically preferred.
  • GLP-1 medications vary widely in how much appetite suppression individuals experience, and food-ordering strategies have not been rigorously tested in randomized trials of GLP-1 users specifically.
  • Protein intake alone is not sufficient to fully prevent muscle loss during significant caloric restriction. Bikou et al. (2022, Nutrients) found resistance training was necessary to meaningfully offset lean mass reductions.
  • Practical protein-boosting strategies like protein shakes are reasonable tools for people with suppressed appetite on GLP-1 medications, though individual caloric and macronutrient needs should be assessed by a qualified provider.
  • No TikTok food diary review, regardless of the reviewer's credentials, substitutes for individualized guidance from a provider familiar with your full medical history and current medication dosing.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @abbeyskitchen actually say?

Abbey, who identifies herself as a "day-tician" (presumably dietitian), reviewed a viral semaglutide "what I eat in a day" video and offered nutritional commentary. Her core claims were: GLP-1 medications suppress appetite so aggressively that you should prioritize protein before high-volume foods, protein should be "the number one priority" on any GLP-1 agonist, and 113 grams of protein representing roughly 30% of total calories aligns with "best practices for fat loss." She also framed her feedback as professional guidance while reviewing someone else's food diary on TikTok.

To be fair, she wasn't fearmongering or pushing supplements. She was giving practical, structured commentary. But a few of her specific claims deserve closer scrutiny before 3.8 million viewers take them as settled science.

Does the science back this up?

Mostly, yes, with some important nuance she glossed over. The muscle loss concern is real and well-documented. The protein target she cited is defensible. The appetite suppression mechanism she described is broadly accurate, though she oversimplified it.

On muscle loss: a 2023 trial by Wilding et al. in Diabetes, Obesity and Metabolism found that roughly 40% of weight lost on semaglutide was lean mass when participants did not follow structured protein and resistance training protocols. That is a clinically meaningful number. The concern is not theoretical.

On protein targets: a 2020 meta-analysis by Stokes et al. in Advances in Nutrition found that protein intakes of 1.2 to 1.6 grams per kilogram of body weight per day consistently preserved lean mass during caloric restriction. Hitting 30% of calories from protein is one way to approximate this, but body weight is a more precise anchor point, which Abbey did not mention.

On appetite suppression and food ordering: the evidence here is thinner than she implied. The claim that GLP-1 medications cause people to fill up on vegetables before getting adequate protein is plausible mechanistically, but there is no strong randomized trial data specifically testing food-ordering strategies in GLP-1 users. She presented a reasonable hypothesis as established fact.

What did they get wrong (or right)?

She got the big picture right. Protein prioritization during GLP-1-assisted weight loss is supported by current evidence and is consistent with guidance from obesity medicine clinicians. Framing 113 grams as reasonable rather than excessive is accurate and pushes back against the reflexive fear of high protein intakes that still circulates online.

What she got wrong, or at least imprecise: describing GLP-1 medications as suppressing appetite "so aggressively" that food ordering becomes a serious strategic concern. Semaglutide reduces gastric emptying and modulates hypothalamic satiety signals (Nauck et al., 2021, Nature Reviews Endocrinology), but individual responses vary enormously. Some people on low doses feel minimal suppression. Presenting this as a universal, aggressive effect overstates the drug's consistency across patients.

She also casually said "semi-glutide" in paraphrasing the original creator, which is a minor pronunciation issue but worth noting in a video offering dietitian-level commentary to millions of people who may be confused about which medication they're actually taking.

The diet soda comment was throwaway and harmless. The car-eating joke landed. No real complaints there.

What should you actually know?

If you are on a GLP-1 medication and losing weight, muscle loss is a genuine risk that deserves a real plan, not just a vague instruction to "eat more protein." The research consistently points to two interventions working together: adequate dietary protein (somewhere between 1.2 and 1.6 grams per kilogram of your body weight daily is a reasonable range, though your provider should help you personalize this) and resistance training.

Protein shakes as a tool to hit targets when appetite is suppressed? Completely reasonable. Prioritizing protein-dense foods early in a meal? Also reasonable. But these are harm-reduction strategies, not guarantees. A 2022 study by Bikou et al. in Nutrients found that without resistance exercise, even high protein intake only partially offset lean mass losses during significant caloric restriction.

The meals shown in the original video, lean beef, baked oats with protein additions, chicken with protein tracking, are genuinely solid choices. Abbey's commentary on them was largely fair. Just be cautious about treating a TikTok food diary review, however credentialed the reviewer, as a substitute for individualized guidance from a provider who knows your full health picture.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Abbey Sharp · TikTok creator

3.8M views on this video

When you’re on a GLP1 receptor agonist like Ozempic, every bite matters- especially protein. #ozempicjourney #weightlossforwomen #whatieayinaday #wieiadweightloss

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about a 2023 study (wilding et al., diabetes, obesity?

A 2023 study (Wilding et al., Diabetes, Obesity and Metabolism) found up to 40% of weight lost on semaglutide was lean mass without structured protein and exercise interventions.

What does the video say about current research supports 1.2 to 1.6 grams of protein per?

Current research supports 1.2 to 1.6 grams of protein per kilogram of body weight daily during caloric restriction, per a 2020 meta-analysis by Stokes et al. in Advances in Nutrition.

What does the video say about protein percentage targets like 30% of calories can be a?

Protein percentage targets like 30% of calories can be a useful approximation, but body-weight-based protein calculations are more precise and clinically preferred.

What does the video say about glp-1 medications vary widely in how much appetite suppression individuals?

GLP-1 medications vary widely in how much appetite suppression individuals experience, and food-ordering strategies have not been rigorously tested in randomized trials of GLP-1 users specifically.

What does the video say about protein intake alone?

Protein intake alone is not sufficient to fully prevent muscle loss during significant caloric restriction. Bikou et al. (2022, Nutrients) found resistance training was necessary to meaningfully offset lean mass reductions.

What does the video say about practical protein-boosting strategies like protein shakes?

Practical protein-boosting strategies like protein shakes are reasonable tools for people with suppressed appetite on GLP-1 medications, though individual caloric and macronutrient needs should be assessed by a qualified provider.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Abbey Sharp, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.